• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于术前增强超声和临床特征的肝细胞癌根治性切除术后早期复发的危险因素。

Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features.

机构信息

Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Department of Ultrasound, Nanjing Drum Tower Hospital, Nanjing, 210008, China.

出版信息

Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241281327. doi: 10.1177/15330338241281327.

DOI:10.1177/15330338241281327
PMID:39212079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11367691/
Abstract

OBJECTIVES

To investigate risk factors for the early recurrence (ER) of hepatocellular carcinoma (HCC) after radical resection based on preoperative contrast-enhanced ultrasound (CEUS) and clinical features to provide guidance for clinical treatment.

METHODS

The retrospective analysis selected 130 HCC patients who underwent radical tumor resection from October 2019 to November 2021. All patients underwent preoperative routine ultrasound examination and CEUS, and the pathology was confirmed as HCC after surgery. The patients were divided into two groups based on whether there is an ER, namely the ER group and the non-ER group. The general clinical, routine and CEUS data of patients were collected, and the factors were selected by using the least absolute shrinkage and selection operator (LASSO) regression. Multivariate logistic regression was used to screen the independent influencing factors of ER. Then a nomogram model was established to predict the risk of ER, and the application value of nomogram through internal validation was evaluated.

RESULTS

Multivariate logistic regression identified several independent factors influencing ER after radical HCC resection. Significant factors included early wash-out phase (95%CI = 0.003-0.206, P = 0.001), liver cirrhosis (95%CI = 2.835-221.224, P = 0.004), incomplete envelope (95%CI = 5.247-1056.130,P = 0.001), multiple lesions (95%CI = 1.110-135.424,P = 0.041), Albumin <40 g/L (95%CI = 2.496-127.223,P = 0.004), and Golgi Protein 73 (GP73) ≥ 85 ng/mL (95%CI = 1.594-30.002, P = 0.010), with all P-values <0.05. The nomogram prediction model constructed based on the results of multivariate logistic regression, demonstrated a ROC curve AUC of 0.879, a sensitivity of 93.5%, a specificity of 66.7%, and a C-index of 0.602, indicating superior diagnostic efficiency compared to independent influencing factors. The ER nomogram prediction model confirmed good discrimination and calibration in internal validation.

CONCLUSION

The CEUS-Clinical combined model effectively monitors the risk of ER in high-risk populations following radical resection of HCC, timely interventions to improve patient prognosis.

摘要

目的

基于术前超声造影(CEUS)和临床特征,探讨肝癌(HCC)根治性切除术后早期复发(ER)的危险因素,为临床治疗提供指导。

方法

回顾性分析 2019 年 10 月至 2021 年 11 月期间 130 例 HCC 患者行根治性肿瘤切除术,所有患者均行术前常规超声检查和 CEUS,术后病理证实为 HCC。根据是否有 ER 将患者分为 ER 组和非 ER 组。收集患者的一般临床、常规和 CEUS 数据,采用最小绝对收缩和选择算子(LASSO)回归选择因素。多因素 logistic 回归筛选 ER 的独立影响因素。然后建立预测 ER 风险的列线图模型,并通过内部验证评估列线图的应用价值。

结果

多因素 logistic 回归确定了影响 HCC 根治性切除术后 ER 的几个独立因素。显著因素包括早期洗脱期(95%CI=0.003-0.206,P=0.001)、肝硬化(95%CI=2.835-221.224,P=0.004)、不完全包膜(95%CI=5.247-1056.130,P=0.001)、多发病灶(95%CI=1.110-135.424,P=0.041)、白蛋白<40g/L(95%CI=2.496-127.223,P=0.004)和高尔基体蛋白 73(GP73)≥85ng/ml(95%CI=1.594-30.002,P=0.010),所有 P 值均<0.05。基于多因素 logistic 回归结果构建的列线图预测模型,ROC 曲线 AUC 为 0.879,灵敏度为 93.5%,特异性为 66.7%,C 指数为 0.602,表明与独立影响因素相比,该模型具有较高的诊断效率。内部验证证实 ER 列线图预测模型具有良好的区分度和校准度。

结论

CEUS-临床联合模型可有效监测 HCC 根治性切除术后高危人群 ER 的风险,及时干预以改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/064e2b6a83bf/10.1177_15330338241281327-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/a48dd17e863e/10.1177_15330338241281327-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/a62b2f1e937d/10.1177_15330338241281327-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/eb90075b5d81/10.1177_15330338241281327-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/4e4b667f96a5/10.1177_15330338241281327-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/064e2b6a83bf/10.1177_15330338241281327-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/a48dd17e863e/10.1177_15330338241281327-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/a62b2f1e937d/10.1177_15330338241281327-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/eb90075b5d81/10.1177_15330338241281327-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/4e4b667f96a5/10.1177_15330338241281327-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa99/11367691/064e2b6a83bf/10.1177_15330338241281327-fig5.jpg

相似文献

1
Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features.基于术前增强超声和临床特征的肝细胞癌根治性切除术后早期复发的危险因素。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241281327. doi: 10.1177/15330338241281327.
2
Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study.预测巴塞罗那临床肝癌(BCLC)分期为B/C期的肝细胞癌患者肝切除术后因复发导致早期癌症相关死亡的列线图:一项多中心研究
BMC Gastroenterol. 2025 Jan 12;25(1):14. doi: 10.1186/s12876-025-03588-6.
3
Multilayer perceptron deep learning radiomics model based on Gd-BOPTA MRI to identify vessels encapsulating tumor clusters in hepatocellular carcinoma: a multi-center study.基于钆贝葡胺增强磁共振成像的多层感知器深度学习放射组学模型用于识别肝细胞癌中包裹肿瘤结节的血管:一项多中心研究
Cancer Imaging. 2025 Jul 7;25(1):87. doi: 10.1186/s40644-025-00895-9.
4
Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinoma.基于超声造影的联合影像组学和临床模型用于术前预测CK19阳性肝细胞癌的开发与验证
Abdom Radiol (NY). 2025 Feb 5. doi: 10.1007/s00261-025-04799-x.
5
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
6
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
7
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.基于微血管侵犯的新型预后列线图预测肝细胞癌R0切除术后患者的生存结局
J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14.
8
Transformer model based on Sonazoid contrast-enhanced ultrasound for microvascular invasion prediction in hepatocellular carcinoma.基于声诺维对比增强超声的变压器模型用于肝细胞癌微血管侵犯预测
Med Phys. 2025 Jul;52(7):e17895. doi: 10.1002/mp.17895. Epub 2025 May 19.
9
Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.基于治疗前 MRI 影像组学和白蛋白-胆红素评分预测不可切除肝细胞癌肝动脉灌注化疗的疗效。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5181-5192. doi: 10.1007/s00432-022-04467-3. Epub 2022 Nov 12.
10
Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.基于 HCC-GRIm 评分构建和验证肝癌患者的列线图。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12013-12024. doi: 10.1007/s00432-023-05037-x. Epub 2023 Jul 8.

引用本文的文献

1
Bibliometrics of artificial intelligence applications in hepatobiliary surgery from 2014 to 2024.2014年至2024年人工智能在肝胆外科应用的文献计量学
World J Gastrointest Surg. 2025 May 27;17(5):104728. doi: 10.4240/wjgs.v17.i5.104728.
2
Development and validation of a model for predicting who can benefit from multiple TACE in HCC patients.开发和验证一个模型,用于预测哪些 HCC 患者可以从多次 TACE 中获益。
Clin Exp Med. 2024 Nov 2;25(1):1. doi: 10.1007/s10238-024-01516-8.

本文引用的文献

1
Golgi Protein 73 Promotes Angiogenesis in Hepatocellular Carcinoma.高尔基体蛋白73促进肝细胞癌血管生成。
Research (Wash D C). 2024 Jul 17;7:0425. doi: 10.34133/research.0425. eCollection 2024.
2
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.AFP-L3 和 DCP 强烈预测肝移植后早期肝细胞癌复发。
J Hepatol. 2023 Dec;79(6):1469-1477. doi: 10.1016/j.jhep.2023.08.020. Epub 2023 Sep 7.
3
A Novel Technology for Resolution of CEUS Imaging Problems in Patients With High BMI and Fatty Liver.
一种解决高BMI和脂肪肝患者CEUS成像问题的新技术。
J Ultrasound Med. 2023 Nov;42(11):2603-2614. doi: 10.1002/jum.16296. Epub 2023 Jul 4.
4
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
5
Overview and countermeasures of cancer burden in China.中国癌症负担概述及对策。
Sci China Life Sci. 2023 Nov;66(11):2515-2526. doi: 10.1007/s11427-022-2240-6. Epub 2023 Apr 13.
6
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models.AFP 疫苗与免疫检查点抑制剂的联合应用可减缓临床前模型中肝细胞癌的进展。
J Clin Invest. 2023 Jun 1;133(11):e163291. doi: 10.1172/JCI163291.
7
Predictors of early and late hepatocellular carcinoma recurrence.预测早期和晚期肝细胞癌复发的因素。
World J Gastroenterol. 2023 Feb 28;29(8):1243-1260. doi: 10.3748/wjg.v29.i8.1243.
8
Advances in post-operative prognostic models for hepatocellular carcinoma.肝细胞癌术后预后模型的研究进展。
J Zhejiang Univ Sci B. 2023 Mar 15;24(3):191-206. doi: 10.1631/jzus.B2200067.
9
Nodules Identified on Surveillance Ultrasound for HCC: CEUS or MRI as the Initial Test?肝癌监测超声发现的结节:以对比增强超声还是磁共振成像作为初始检查?
J Ultrasound Med. 2023 Jun;42(6):1181-1190. doi: 10.1002/jum.16183. Epub 2023 Feb 20.
10
Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance.超声检查早期肝癌时的盲区的影响。
PLoS One. 2022 Sep 16;17(9):e0274747. doi: 10.1371/journal.pone.0274747. eCollection 2022.